Program:  Address of JSHR President Special Lecture

Address of JSHR President

Friday, June 24th, 2022

Chair:

13：10～13：40

Room 1（2Fkouyou）

Hiroto Miwa（Emeritus professor, Hyogo Medical University / Kawanishi City Medical Center）

Strategies for the Diagnosis and treatment of Gastric Cancer after H. pylori eradication.
Kazunari Murakami

（Department of Gastroenterology, Faculty of Medicine, Oita University）

Special Lecture 1

Friday, June 24th, 2022

Chair:

14：20～14：50

Room 1（2Fkouyou）

Hiroyuki Okada（Department of Gastroenterology, Japanese Red Cross Himeji Hospital）

Pathogenic metabolites in Helicobacter pylori that exacerbate gastritis
Sho Yamasaki（Research Institute for Microbial Diseases（RIMD）/ 

Immunology Frontier Research Center（IFReC）,Osaka University）

Special Lecture 2

Saturday, June 25th, 2022

Chair:

10：40～11：10

Takashi Kawai

（Tokyo Medical University）

Gastric cancer prevention by H. pylori eradication therapy:
Current status and remaining issues.
Kentaro Sugano（Honorary Professor, Jichi Medical University）

122

Room 1（2Fkouyou）

Program:  Overseas Special Lecture Best Presentation Award Academic Award（Clinical Research）

Overseas Special Lecture 1

Friday, June 24th, 2022

Chair:

13：50～14：20

Room 1（2Fkouyou）

Naomi Uemura

（National Center for Global health and Medicine, Kohnodai hospital）

Helicobacter pylori infection, eradication, GERD and the microbiome
Nimish Vakil

（University of Wisconsin School of Medicine and Public Health, Madison, WI, USA）

Overseas Special Lecture 2

Saturday, June 25th, 2022

Chair:

11：20～11：50

Room 1（2Fkouyou）

Mototsugu Kato（Hokkaido Cancer Society）

Revolution in the diagnosis and treatment of Helicobacter pylori infections in westerncountries: West meets East.
David Y. Graham

（Baylor College of Medicine, Houston, TX, USA.）Best Presentation Award

Friday, June 24th, 2022

Chair:

16：00～16：30

Room 1（2Fkouyou）

Room 1（2Fkouyou）

Jiro Watari

（Kinentou Hospital）

Antisecratory agents drive human gut microbiome variation
Naoyoshi Nagata（Department of Gastroenterological Endoscopy, Tokyo Medical University）

Academic Award（Clinical Research）
Friday, June 24th, 2022

Chair:

16：30～17：00

Makoto Sasaki（Department of Gastroenterology, Aichi Medical University School of Medicine）

Toward the society with complete Helicobacter eradication
Yoshihiro Hirata

（Division of advanced genome medicine, The Institute of Medical Science, The University of Tokyo）

123

Program:  JSHR Educational Lecture Qualification exam

JSHR Educational Lecture（Qualification Renewal）
Saturday, June 25th, 2022

Chair:

Lecture 1

16：00～17：00

Room 1（2Fkouyou）

Akiko Shiotani

（Kawasaki Medical School Internal Medicine）

Basics for safe and effective H. pylori eradication therapy
Takahisa Furuta

（Center for Clinical Research Hamamatsu University School of Medicine）

Lecture 2

Eradication of Helicobacter pylori and gastric cancer risk: Up to date
Motowo Mizuno

（Kurashiki Central Hospital, Department of Gastroenterology and Hepatology）

JSHR Educational Lecture（New Qualification）
Sunday, June 26th, 2022

Chair:

10：00～11：00

Streaming Distribution

Hidekazu Suzuki（Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai
University School of Medicine）（Basic Research）
Basic research of Helicobacter pylori
Kinnosuke Yahiro（Department of Microbiology and Infection Control Sciences, Division of Biological Sciences, Kyoto
Pharmaceutical University）（Clinical Research）
Diagnosis and treatment of H. pylori infection-Based on guideline of H. pylori infectionSeiji Futagami

（Division of Gastroenterology, Nippon Medical School）

Qualification exam

Sunday, June 26th, 2022

11：30～12：00

124

Streaming Distribution

Program:  Eradication Registry Briefing Session/Ethics Lecture Morning Seminar

Eradication Registry Briefing Session/Ethics Lecture
Friday, June 24th, 2022

Chair:

Room 1（2Fkouyou）

Shogo Kikuchi（Department of Public Health, Aichi Medical University School of Medicine）

Morning Seminar 1

Friday, June 24th, 2022

Chair:

17：10～17：40

8：00～8：50

Room 1（2Fkouyou）

Hidekazu Suzuki（Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai
University School of Medicine）

Sponsored by:  AI Medical Service Inc.

The Global Challenge of Endoscopic AI Originated in Japan
Tomohiro Tada

（AI Medical Service Inc. / Tada Tomohiro the Institute of Gastroenterology & Proctology）

Morning Seminar 2

Saturday, June 25th, 2022

Chair:

8：00～8：50

Shotaro Nakamura

Room 1（2F（International University of Health and Welfare, School of Medicine / Center for Gastroenterology, Takagi Hospital）

Sponsored by:  Otsuka Pharmaceutical Co., Ltd.

Economic Impact of Helicobacter pylori Eradication Strategy
Akiko Kowada

（Health Sciences University of Hokkaido）

Ligth and shadow of acid secretion inhibitors
Chika Kusano（Department of Gastroenterology, Kitasato University School of Medicine）

125

kouyou）

Program:  Luncheon Seminar

Luncheon Seminar 1

Friday, June 24th, 2022

Chair:

12：10～13：00

Room 1（2Fkouyou）

Yasuhiro Fujiwara

（Osaka Metropolitan University Graduate School of Medicine）

Sponsored by:  Otsuka Pharmaceutical Co., Ltd./ Takeda Pharmaceutical Co., Ltd.

Optimizing Management of GERD
～Based on the Clinical Practice Guidelines for GERD 2021～
Kunio Kasugai

（Aichi Medical University）

Luncheon Seminar 2

Friday, June 24th, 2022

Chair:

12：10～13：00

Room 2（1F

naruo）

Room 3（2F

atago）

Kentaro Sugano（Jichi Medical University）

Sponsored by:  Miyarisan Pharmaceutical Co., Ltd.

Helicobacter pylori infection and intestinal microbiota
Shigeru Kamiya

（Professor Emeritus, Kyorin University）

Luncheon Seminar 3

Friday, June 24th, 2022

Chair:

12：10～13：00

Kazuhiko Inoue（Junpukai Health Maintenance Center）

Sponsored by:  Eiken Chemical Co., Ltd.

Usefulness of new test kits in non-invasive diagnosis for H. pylori infection.
Tadashi Shimoyama（Aomori General Health Examination Center）

126

Program:  Luncheon Seminar

Luncheon Seminar 4

Saturday, June 25th, 2022

Chair:

12：00～12：50

Room 1（2Fkouyou）

Kazunari Murakami

（Department of Gastroenterology, Oita University Faculty of Medicine）

Sponsored by:  Biofermin Pharmaceutical Co., Ltd / Taisho Pharmaceutical Co., Ltd.

Drugs-induced small intestinal injury and gut microbiome
Toshio Watanabe（Department of Premier Preventive Medicine, Osaka Metropolitan University Graduate School of
Medicine）

Luncheon Seminar 5

Saturday, June 25th, 2022

Chair:

12：00～12：50

Room 2（1F

naruo）

Hiroto Miwa

（Hyogo Medical University）

Sponsored by:  AstraZeneca K.K.

Long term PPI therapy effects on H. pylori and the gut microbiome
Nimish Vakil

（University of Wisconsin School of Medicine and Public Health, Madison, WI, USA）

Luncheon Seminar 6

Saturday, June 25th, 2022

Chair:

12：00～12：50

Room 3（2F

Nobuo Aoyama（Aoyama Clinic：GI Endoscopy & IBD Center）

Sponsored by:  Fujifilm Irvine Scientific

H. pylori genome structure and antibody reaction
Kenji Yokota

（Graduate School of Health Science, Okayama University）

Reconsidering the effective use of serum H. pylori antibodies in Japan
Kazuhiko Inoue（Junpukai Health Maintenance Center）

127

atago）

Program:  Afternoon Seminar

Afternoon Seminar 1

Friday, June 24th, 2022

Chair:

15：05～15：55

Room 1（2Fkouyou）

Yoshihiro Fukuda

（Dainikyoritsu Hospital）

Sponsored by:  Denka Co., Ltd.

Serum antibody test for screening of Helicobacter pylori infection diagnosis andGastric cancer
Masanori Ito

（Department of General Internal Medicine, Hiroshima University Hospital）

Afternoon Seminar 2

Friday, June 24th, 2022

Chair:

15：05～15：55

Room 2（1F

naruo）

Tadashi Shimoyama（Aomori General Health Examination Center）

Sponsored by:  Mizuho Medy Co., Ltd.

Usefulness of novel rapid clarithromycin-resistant H. pylori diagnosis for eradication
therapy.
Mototsugu Kato（Hokkaido Cancer Society Sapporo Cancer Screening Center）

Afternoon Seminar 3

Saturday, June 25th, 2022

Chair:

14：35～15：25

Room 1（2F

Ken Haruma

kouyou）（Department of General Internal Medicine 2, Kawasaki Medical School General Medical
Center / Junpukai Health Maintenance Center）

Sponsored by:  Fujifilm Medical Co., Ltd.

Current status and future of endoscopy diagnosis by nasal endoscopy
Takashi Kawai

（Department of Gastroenterological Endoscopy, Tokyo Medical University）

128

Program:  Afternoon Seminar Symposium

Afternoon Seminar 4

Saturday, June 25th, 2022

Chair:

14：35～15：25

Room 2（1F

naruo）

Seiji Futagami

（Division of Gastroenterology, Nippon Medical School）

Sponsored by:  Zeria Pharmaceutical Co., Ltd.

Is it enough to suppress acid secretion?
A“systematic”treatment strategy for“complex”upper abdominal symptoms
Toshihisa Takeuchi

（Osaka Medical and Pharmaceutical University Hospital Endoscopy Center）

Symposium 1

Friday, June 24th, 2022

9：00～10：30

Room 1（2Fkouyou）

Current trends and issues for differential diagnosis of H. pylori infectious
statusChair:

Masanori Ito

（Department of General Internal Medicine, Hiroshima University Hospital）

Akiko Shiotani

（Kawasaki Medical School）

Special Remarks:
Commentator:

S1-1

Nobuo Aoyama（Aoyama Medical Clinic）

Kengo Tokunaga

（Department of General Medicine, Kyorin University School of Medicine）

Status of H. pylori infection by interview
Masahiko Ohtaka

（Yamanashi Koseiren Health Care Center Internal medicine）

S1-2

Discordant cases of H. pylori antibody EIA and LA methods in our hospital
Kumiko Ueda

（Department of Gastroenterology, Juntendo University School of Medicine）

S1-3

Comparison of LETIA and ELISA methods for measurement of serum Helicobacter
pylori antibody levels
Masami Tanaka（Department of Gastroenterology, Toranomon Hospital）

S1-4

Difference of seropositivity among 4 kits after H. pylori eradication: A 6-year follow-up.
Kohei Yasuda（Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine）

S1-5

Diagnosis of H. pylori infectious status using the hybrid ABC and its practical use
Masayuki Inui

（Inui clinic of internal medicine）

129

Program:  Symposium

S1-6

Challenging diagnosis of concurrent H. pylori infection with autoimmune gastritis
Tohru Kotera（Department of Medical Examination, Uji-Tokushukai Medical Center）

S1-7

Association between autoimmune gastritis and H. pylori infection
Naoki Sumi

（Department of health care medicine, Kawasaki Medical School）

S1-8

SNP analysis in PSCA related with gastric mucosal atrophy
Takuki Sakaguchi（Department of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University）

Symposium 2

Friday, June 24th, 2022

10：30～12：00

Room 1（2Fkouyou）

Progress in endoscopic diagnosis of gastritis and gastric cancer according to
the background mucosa
Chair:

Mitsuru Kaise（Department of Gastroenterology, Nippon Medical School）

Mitsuhiro Fujishiro（Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo）

Special Remarks:

Commentator:

S2-1

Kazuhide Higuchi（2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical
University）

Mitsushige Sugimoto（Department of Gastroenterological Endoscopy, Tokyo Medical University）

The features of autoimmune gastritis with H. pylori infection
Mototsugu Kato（National Hospital Organization Hakodate National Hospital）

S2-2

Clinicopathological study of gastric cancer cases with autoimmune gastritis (AIG)
Yuichi Hara

（Division of Gastroenterology, Matsuyama Red-cross Hospital）

S2-3

LCI and Histological Findings for Mucosal Redness after H. pylori Eradication
Therapy
Hiraku Misawa（Kawasaki Medical School）

S2-4

Endoscopic diagnosis of H. pylori infectious status using the endoscopic ABC
classification
Masayuki Inui

（Inui clinic of internal medicine）

S2-5

Third-generation ultrathin endoscopy using IEE to evaluate gastritis:a randomized controlled trial
Mitsushige Sugimoto（Department of Gastroenterological Endoscopy, Tokyo Medical University Hospital）

130

Program:  Symposium

S2-6

Analysis for high-risk group of gastric cancer according to Kyoto classification;
multicenter study
Masashi Kawamura（Department of Gastroenterology, Sendai City Hospital）

S2-7

Qualitative diagnosis of gastric cancer based on endoscopy-based Kyoto classification ofgastritis
Osamu Toyoshima

（Toyoshima Endoscopy Clinic）

S2-8

Comparison of endocytoscopic diagnosis between H. pylori infected and eradicatedgastric cancer
Hiroto Noda

（Department of Gastroenterology, Nippon Medical School Hospital）

S2-9

Endoscopic and clinicopathological features of early gastric cancer in H. pylori
uninfected patient
Nobuyuki Suzuki

（Department of Gastroenterology, Juntendo University School of Medicine）

Symposium 3

Saturday, June 25th, 2022

9：00～10：30

Room 1（2Fkouyou）

Gastric cancer prevention strategies, perspective and problems
Chair:

Shogo Kikuchi（Department of Public Health, Aichi Medical University School of Medicine）

Katsuhiro Mabe（Junpukai Health Maintenance Center, Kurashiki）

Special Remarks:

Masahiro Asaka（Health Sciences University of Hokkaido）

S3-1（Keynote Lecture）
The issues and strategy in post-Hp eradication era for gastric cancer prevention
Toshiro Sugiyama

（Health Sciences University of Hokkaido, Advanced Research Center）

S3-2

Long-term prediction of gastric cancer incidence considering H. pylori prevalence
Sayo Kawai

（Department of Public Health, Aichi Medical University School of Medicine）

S3-3

The results of H. pylori screening which is trying as prevention of gastric cancer inour hospital
Momoko Tsuda

（Department of Gastroenterology, National Hospital Organization Hakodate National Hospital）

S3-4

Current status and future direction of gastric cancer screening in Yamagata Prefecture
Ko Nagino（Department of Gastrointestinal, Yamagata Prefectural Central Hospital / Central Committee for Gastrointestinal Screening, Yamagata Medical Association）

131

Program:  Symposium Panel Discussion

S3-5

Countermeasures for gastric cancer prevention through population-based X-ray
screening program.
Takashi Chiba

（Miyagi Cancer Society）

S3-6

Strategies for eliminating death from gastric cancer in Hokkaido
Katsuhiro Mabe（Junpukai Health Maintenance Center Kurashiki / 
National Hospital Organization Hakodate National Hospital）

S3-7

Examination of status after 5 years for each group diagnosed by ABC classification
Daisuke Chinda

（Division of Endoscopy, Hirosaki University Hospital）

S3-8

Problems of H. pylori screening in gastric cancer prevention
Kazuhiko Inoue（Junpukai Health Maintenance Center）

S3-9

Unavoidable decisions and demanded evidences for gastric cancer prevention in future
Shogo Kikuchi（Department of Public Health, Aichi Medical University School of Medicine）

Panel Discussion 1

Friday, June 24th, 2022

9：00～10：30

Room 2（1F

naruo）

Dyspepsia and gut microbiota
Chair:

Tomoari Kamada（Department of health Care Medicine, Kawasaki Medical School）

Hidekazu Suzuki（Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai
University School of Medicine）

Special Remarks:

Seiji Futagami

（Division of Gastroenterology, Nippon Medical School）

PD1-1（Keynote Lecture）
Functional dyspepsia - pathogenesis and involvement of Dysbiosis
Ken Haruma

（General Internal Medicine 2, Kawasaki Medical School General Medical Center）

PD1-2

Effects of Proton Pump Inhibitors on the Intestinal Barrier in Mice Under Stressed
Conditions
Shingo Takashima

（Osaka Metropolitan University Hospital Premier Preventive Medicine）

PD1-3

Chronic epigastric pain and gastric microbiota
Takashi Ueda

（Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University
School of Medicine）

132

Program:  Panel Discussion

PD1-4

Gastric environment and symptom generation: prospects from Hp-associated dyspepsia
research
Juntaro Matsuzaki

（Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy）

Panel Discussion 2

Saturday, June 25th, 2022

9：00～10：30

Room 2（1F

naruo）

Current status and response to H. pylori infection in children and adolescents
Chair:

Masumi Okuda

（Department of Pediatrics, Hyogo Medical University）

Toshiaki Shimizu（Department of Pediatrics, Juntendo University Faculty of Medicine）

Special Remarks:

PD2-1

Yoshihiro Fukuda

（Dainikyoritsu Hospital）

Study of H. pylori infection rate in 3-year-old children
Tadashi Matsubayashi（Department of Pediatrics, Seirei Hamamatsu Hospital）

PD2-2

Clinical evaluation of a novel H. pylori stool antigen test using bioluminescent enzyme
immunoassay
Toshihiko Kakiuchi

（Saga University Hospital）

PD2-3

Does H. pylori-associated dyspepsia exist in childhood?
Tamaki Ikuse（Department of Pediatrics, Juntendo University Faculty of Medicine）

PD2-4

Antibiotic resistance of Helicobacter pylori and key factors inducing the resistance inpediatric patients
Tamaki Ikuse（Department of Pediatrics, Juntendo University Faculty of Medicine）

PD2-5

The results of secondary eradication of H. pylori in first-year high school students in
Yokosuka
Yasuhiro Mizuno

（Ma-ru Clinic Yokosuka）

PD2-6

A Study of dual therapy with vonoprazan for H. pylori Positive adolescent
Chika Kusano（Division of Gastroenterology and Hepatology, Department of Medicine, Kitasato University School of
Medicine）

133

Program:  Workshop

Workshop 1

Friday, June 24th, 2022

10：30～12：00

Room 2（1F

naruo）

Current progress on basic aspects of Helicobacter research
Chair:

Takako Osaki（Department of Infections Diseases, Kyorin University School of Medicine）

Shin Maeda

（Department of Gastroenterology, Yokohama City University）

Special Remarks:

Shigeru Kamiya（Kyorin University）

WS1-1（Keynote Lecture）
Current Status of Basic Researches for Helicobacter Infection
Yoshio Yamaoka

（Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine）

WS1-2

Changes in gastric microflora in the Helicobacter pylori infection model using MPS
mice
Fuhito Hojo

（Institute of Laboratory Animals, Graduate School of Medicine, Kyorin University）

WS1-3

Cellular effect by Helicobacter pylori and co-cultured nitrate-reduction bacteria
Hinako Ojima

（Graduate school of health sciences Okayama university）

WS1-4

A novel identified non-Helicobacter bacteria associated with the development of gastriccancerHitoshi Tsugawa（Transkingdom Signaling Research Unit, Division of Host Defense Mechanism, Tokai University Schoolof Medicine）

WS1-5

Epithelial damage and activation by Non-Helicobacter gastric microbiome
Yoku Hayakawa（Department of Gastroenterology, The University of Tokyo）

WS1-6

Analysis of platelet activation induced by H. pylori membrane protein, Lpp-20.
Asako Kimura（International University of Health and Welfare, Department of Medical Technology and Sciences）

WS1-7

Epigenome microevolution associated with DNA methyltransferase specificity changes
in H. pylori.
Masaki Fukuyo（Department of Molecular Oncology School of Medicine, Chiba University / Department of Applied
Genomics, Kazusa DNA Research Institute）

WS1-8

H. pylori induces viral receptor expression via a type IV secretion and promotes EBV
infection
Hisashi Iizasa

（Department of Microbiology, Faculty of Medicine, Shimane University）

134

Program:  Workshop

WS1-9

Comparable genetic alterations between gastric cancers with current and past H.
pylori infection
Sho Tsuyuki

（Division of Epigenomics, National Cancer Center Research Institute / Department of Gastroenterology,
Yokohama City University Graduate School of Medicine）

Workshop 2

Friday, June 24th, 2022

13：30～15：00

Room 2（1F

naruo）

Improvements and problems of H. pylori eradication therapy- from initial therapy to rescue therapy Chair:

Takahisa Furuta

（Center for Clinical Research Hamamatsu University School of Medicine）

Tadashi Shimoyama（Aomori general Health Examination Center）

Special Remarks:

WS2-1

Kiichi Satoh（Department of Gastroenterology, International University of Health and Welfare
Hospital）

Development of a scoring system for predicting clarithromycin-resistant H. pylori
Sho Suzuki

（International University of Health and Welfare Ichikawa Hospital）

WS2-2

The efficacy of vonoprazan based tailored first-line eradication therapy on drug
susceptibility test
Masaki Murata

（Department of Gastroenterology, National Hospital Organization Kyoto Medical Center）

WS2-3

Multicenter intervention trial of vonoprazan and high dose amoxicillin dual therapy forH. pylori
Soichiro Sue

（Yokohama City University Hospital）

WS2-4

Evaluation of low-dose rifabutin based regimen as a third- or later-line H. pylori
eradication
Kazumi Inokuchi（Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University Schoolof Medicine）

WS2-5

A risk factor for drug eruption in H. pylori eradication therapy
Tomohiro Higuchi

（First Department of Medicine, Hamamatsu University School of Medicine）

WS2-6

Study of symptoms around H. pylori eradication the view of the level gastric mucosal
atrophy
Kazutake Oguma

（Department of Internal Medicine, Asoka Hospital）

135

Program:  Workshop

Workshop 3

Saturday, June 25th, 2022

13：00～14：30

Room 1（2Fkouyou）

Advantages and disadvantages of declining H. pylori infection
Chair:

Katsunori Iijima（Department of Gastroenterology, Akita University Graduate School of Medicine）

Akihito Nagahara（Department of Gastroenterology, Juntendo University School of Medicine）

Special Remarks:
Commentator:

Shin’ichi Takahashi（Department of Internal Medicine, Kosei hospital）

Toshio Watanabe（Department of Premier Preventive medicine, Osaka Metropolitan University）

WS3-1（Invited Lecture）
H. pylori and gastric cancer
Yoshihiro Hirata

（Division of advanced genome medicine, The Institute of Medical Science, The University of Tokyo）

WS3-2

Predicted gastric cancer incidence, mortality, effects of Hp eradication through 2050
Ryota Niikura

（Gastroenterological Endoscopy, Tokyo Medical University）

WS3-3（Invited Lecture）
Relationship between Helicobacter pylori and gastroesophageal reflux disease
Tomoyuki Koike（Division of Gastroenterology, Tohoku University Graduate School of Medicine）

WS3-4（Invited Lecture）
H. pylori and peptic ulcer disease
Kiichi Satoh（Department of Gastroenterology, International University of Health and Welfare Hospital）

WS3-5

Relationship between H. pylori infection and gastric mucosal injuries in patients taking
aspirin
Yuji Shimada（Juntendo University Shizuoka Hospital）

WS3-6

Association of H. pylori with Inflammatory Bowel Disease
Satoru Takahashi（Hamamatsu University Hospital）

WS3-7（Invited Lecture）
Effect of decrease of H. pylori prevalence on mortality
Shogo Kikuchi（Department of Public Health, Aichi Medical University School of Medicine）

136

Program:  Oral Session

Oral Session 1

Friday, June 24th, 2022

9：00～9：30

Room 3（2F

atago）

Gastric Cancer 1
Chair:

O1-1

Eiji Umegaki

（Division of Gastroenterology & Hepatology, Kawasaki Medical School）

Characteristics of SM invasive gastric cancer detected after eradication therapy in our
hospitalKazuo Yashima（Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University）

O1-2

Significance of H. pylori infection in patients with familial adenomatous polyposis
Keisuke Nakai（Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo Medical
University）

O1-3

Analysis of patient characteristics in patients undergoing gastric ESD after H. pylori
eradication
Hideharu Ogiyama

（Itami City Hospital）

Oral Session 2

Friday, June 24th, 2022

9：40～10：10

Room 3（2F

atago）

Gastric Cancer 2
Chair:

O2-1

Daisuke Asaoka

（Juntendo Tokyo Koto Geriatric Medical Center）

Assessment of factors related to gastric cancer prevention using medical examinationdata
Kyoko Ito（Centre for Preventive Medicine, The Jikei University School of Medicine）

O2-2

Promotion of H. pylori eradication for 20 years decrease advanced gastric cancer
Yoshihiro Ohno（Department of diagnostic patholoty, Tone chuou hospital）

O2-3

Gastric xanthelasma and molecular alterations as a predictive marker for synchronous/
metachronous gastric cancer
Hirotsugu Eda（Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo Medical
University）

137

Program:  Oral Session

Oral Session 3

Friday, June 24th, 2022

10：30～11：00

Room 3（2F

atago）

Diagnostic
Chair:

O3-1

Masahiko Ohtaka

（Yamanashi Koseiren Health Care Center）

Diagnosis of H. pylori-infected gastritis with Dedicated Vehicle for Transnasal
Endoscopy
Satoshi Ikeda

（Ikeda hospital Surgery･Gastroenterology）

O3-2

Evaluation of seropositivity of E-plate and LZ-II in patients with successful H. pylori
eradication
Yasumitsu Araki（Mutsu General Hospital）

O3-3

Abstract Withdrawal

Oral Session 4

Saturday, June 25th, 2022

10：40～11：20

Room 2（1F

naruo）

Eradication Therapy and Others
Chair:

O4-1

Noriyuki Horiki

（Mie University School of Medicine）

Clinical study of Helicobacter pylori eradication therapy with sitafloxacin
Tatsushi Omatsu

（Department of Gastroenterology and Hepatology, North Medical Center, Kyoto Prefectural Universityof Medicine / Department of Gastroenterology and Hepatology, Asahi University Hospital）

O4-2

Current problems in the eradication of H. pylori in Japan
Soichiro Sue

（Yokohama City University Hospital）

O4-3

Examination of changes in the gut microbiome after Helicobacter pylori eradication inyoung adults.
Shotaro Okanoue（Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine）

O4-4

Influence of the sanitary environment during childhood on Helicobacter pylori infection
Takunori Ueno

（Division of Gastroenterology, Tsukuba Central Hospital）

138

Program:  Oral Session

Oral Session 5

Saturday, June 25th, 2022

13：00～13：30

Room 2（1F

naruo）NHPH and Others
Chair:

O5-1

Tadayoshi Okimoto（Department of Gastroenterology Faculty of Medicine, Oita University）

Prevalence of non-Helicobacter pylori Helicobacter in Myanmar and Nepal inComparison with Japan
Masahiko Nakamura（Ohmura Satoshi Memorial Institute, Kitasato University）

O5-2

A clinical study on eradication therapy for non-Helicobacter pylori Helicobacter(NHPH)
Toshihisa Tsukadaira（Department of Internal Medicine, Kenwakai Hospital）

O5-3

Upper gastrointestinal endoscopic findings in functional constipation and irritable bowel
syndrome
Koji Otani（Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine）

Oral Session 6

Saturday, June 25th, 2022

13：40～14：10

Room 2（1F

naruo）

Basic Research
Chair:

O6-1

Juntaro Matsuzaki

（Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy）

Helicobacter pylori proteins implicated in host interaction
Ichizo Kobayashi

（Research Center for Micro-Nano Technology, HOSEI University）

O6-2

Nitrate-reducing bacteria in the gastric mucosa in Helicobacter pylori infected
gastritis
Sakiko Kuraoka

（Department of Gastroenterology and Hepatology, Okayama University Hospital）

O6-3

Nucleotide Polymorphism in Outer Membrane Protein and Flagella Associated with
Biofilm Formation
Kartika Afrida Fauzia

（Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University）

139